Farther Finance Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History

Farther Finance Advisors’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$534	Hold	200	–	–	﹤0.01%	5522
2026 Q1	$510	Hold	200	–	–	﹤0.01%	5267
2025 Q4	$422	Hold	200	–	–	﹤0.01%	5082
2025 Q3	$342	Hold	200	–	–	﹤0.01%	4623
2025 Q2	$232	Buy	+200	New	+$215	﹤0.01%	4182

Other funds holding ABOS

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Clune & Associates Chicago, Illinois $661M AUM 21.51% 1-Year Est. Return

Farther Finance Advisors's ABOS Position: Q2 2026 in Review

Farther Finance Advisors held its Acumen Pharmaceuticals (ABOS) position steady in Q2 2026 at 200 shares worth $534. The position accounts for ﹤0.01% of the portfolio, ranked #5522.

Farther Finance Advisors first reported a position in ABOS in Q2 2025 and has held it in 5 quarters since. 4 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

Farther Finance Advisors held 200 shares of Acumen Pharmaceuticals worth $534 as of Q2 2026.
Farther Finance Advisors left its Acumen Pharmaceuticals share count unchanged in Q2 2026.
Acumen Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5522 holding.
Farther Finance Advisors first reported a position in Acumen Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
4 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.